Cargando…

Comparison of Peripheral and Central Schizophrenia Biomarker Profiles

We have recently shown that a molecular biomarker signature comprised of inflammatory, hormonal and growth factors occurs in the blood serum from first onset schizophrenia patients. Here, we use the same platform to investigate post mortem brain tissue (Brodmann area 10) from schizophrenia patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harris, Laura W., Pietsch, Sandra, Cheng, Tammy M. K., Schwarz, Emanuel, Guest, Paul C., Bahn, Sabine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484150/ https://www.ncbi.nlm.nih.gov/pubmed/23118852 http://dx.doi.org/10.1371/journal.pone.0046368

Ejemplares similares

Proteomic profiling in schizophrenia: enabling stratification for more effective treatment
por: Guest, Paul C, et al.
Publicado: (2013)

Biomarker discovery in human cerebrospinal fluid: the need for integrative metabolome and proteome databases
por: Schwarz, Emanuel, et al.
Publicado: (2012)

Integrative proteomic analysis of the NMDA NR1 knockdown mouse model reveals effects on central and peripheral pathways associated with schizophrenia and autism spectrum disorders
por: Wesseling, Hendrik, et al.
Publicado: (2014)

Clinical bioinformatics for complex disorders: a schizophrenia case study
por: Schwarz, Emanuel, et al.
Publicado: (2009)

Distinct Molecular Phenotypes in Male and Female Schizophrenia Patients
por: Ramsey, Jordan M., et al.
Publicado: (2013)

Proteomics: improving biomarker translation to modern medicine?
por: Guest, Paul C, et al.
Publicado: (2013)

Identification of blood-based molecular signatures for prediction of response and relapse in schizophrenia patients
por: Schwarz, E, et al.
Publicado: (2012)

Validation of a Blood-Based Laboratory Test to Aid in the Confirmation of a Diagnosis of Schizophrenia
por: Schwarz, Emanuel, et al.
Publicado: (2010)

The application of selective reaction monitoring confirms dysregulation of glycolysis in a preclinical model of schizophrenia
por: Martins-de-Souza, Daniel, et al.
Publicado: (2012)

Diabetic db/db mice exhibit central nervous system and peripheral molecular alterations as seen in neurological disorders
por: Ernst, A, et al.
Publicado: (2013)

Multimodel inference for biomarker development: an application to schizophrenia
por: Cooper, Jason D., et al.
Publicado: (2019)

Evidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophrenia
por: van Beveren, N J M, et al.
Publicado: (2014)

Gene expression in the prefrontal cortex during adolescence: implications for the onset of schizophrenia
por: Harris, Laura W, et al.
Publicado: (2009)

MiRNAs of peripheral blood as the biomarker of schizophrenia
por: He, Kuanjun, et al.
Publicado: (2017)

SERUM BIOMARKERS FOR PSYCHIATRIC DISORDERS
por: Bahn, Sabine
Publicado: (2014)

The role of proteomics in depression research
por: Martins-de-Souza, Daniel, et al.
Publicado: (2009)

The druggable schizophrenia genome: from repurposing opportunities to unexplored drug targets
por: Lago, Santiago G., et al.
Publicado: (2022)

Central Nervous System and Peripheral Inflammatory Processes in Alzheimer’s Disease: Biomarker Profiling Approach
por: Delaby, Constance, et al.
Publicado: (2015)

Building Predictive Models for Schizophrenia Diagnosis with Peripheral Inflammatory Biomarkers
por: Kozyrev, Evgeny A., et al.
Publicado: (2023)

Altered T-Cell Function in Schizophrenia: A Cellular Model to Investigate Molecular Disease Mechanisms
por: Craddock, Rachel M., et al.
Publicado: (2007)

Proteomic Profiling as a Diagnostic Biomarker for Discriminating Between Bipolar and Unipolar Depression
por: Kittel-Schneider, Sarah, et al.
Publicado: (2020)

Relationship between central and peripheral fatty acids in humans
por: Guest, Jade, et al.
Publicado: (2013)

The Cerebral Microvasculature in Schizophrenia: A Laser Capture Microdissection Study
por: Harris, Laura W., et al.
Publicado: (2008)

Gene expression profiling in peripheral blood mononuclear cells of early-onset schizophrenia
por: Sun, Li, et al.
Publicado: (2015)

Metabolic changes in schizophrenia and human brain evolution
por: Khaitovich, Philipp, et al.
Publicado: (2008)

Proteomic analysis of post mortem brain tissue from autism patients: evidence for opposite changes in prefrontal cortex and cerebellum in synaptic connectivity-related proteins
por: Broek, Jantine AC, et al.
Publicado: (2014)

Proteomic Enrichment Analysis of Psychotic and Affective Disorders Reveals Common Signatures in Presynaptic Glutamatergic Signaling and Energy Metabolism
por: Gottschalk, Michael G., et al.
Publicado: (2015)

MicroRNA Expression Aberration as Potential Peripheral Blood Biomarkers for Schizophrenia
por: Lai, Chi-Yu, et al.
Publicado: (2011)

Peripheral biomarkers of treatment-resistant schizophrenia: Genetic, inflammation and stress perspectives
por: Jiao, Shimeng, et al.
Publicado: (2022)

Peripheral Complement Factor-Based Biomarkers for Patients with First-Episode Schizophrenia
por: Cao, Yin, et al.
Publicado: (2023)

S11. PLASMA LEPTIN AND ANTHRANILIC ACID IN SCHIZOPHRENIA PATIENTS: NEW BIOMARKERS OF PREDISPOSITION TO METABOLIC ABNORMALITIES
por: Steiner, Johann, et al.
Publicado: (2020)

Identification of an age-dependent biomarker signature in children and adolescents with autism spectrum disorders
por: Ramsey, Jordan M, et al.
Publicado: (2013)

Innate Immune Cells and C-Reactive Protein in Acute First-Episode Psychosis and Schizophrenia: Relationship to Psychopathology and Treatment
por: Steiner, Johann, et al.
Publicado: (2020)

Immunomodulatory Effects of Probiotic Supplementation in Schizophrenia Patients: A Randomized, Placebo-Controlled Trial
por: Tomasik, Jakub, et al.
Publicado: (2015)

Molecular Sex Differences in Human Serum
por: Ramsey, Jordan M., et al.
Publicado: (2012)

Metabolic Profiling of CSF: Evidence That Early Intervention May Impact on Disease Progression and Outcome in Schizophrenia
por: Holmes, Elaine, et al.
Publicado: (2006)

Central and Peripheral Changes in FOS Expression in Schizophrenia Based on Genome-Wide Gene Expression
por: Huang, Jing, et al.
Publicado: (2019)

Chromatin from Peripheral Blood Mononuclear Cells as Biomarkers for Epigenetic Abnormalities in Schizophrenia
por: Gavin, David P., et al.
Publicado: (2009)

C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review
por: Fond, Guillaume, et al.
Publicado: (2018)

Peripheral Biomarkers in Schizophrenia: A Meta-Analysis of Microarray Gene Expression Datasets
por: Piras, Ignazio S, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_f3id2ee9vamdt0lmnjoe5lupr4